603122.SHG Cowealth Medical China Co.Ltd.

Healthcare Biotechnology Shanghai Stock Exchange
11.08 CNY
Close of Nov 5, 2026
9.07 31.22
Market cap
CNY 4.41B
P/E
-
P/B
4.15x
ROE
-0.7%
Dividend yield
1.19%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 603122.SHG undervalued?

Graham number

The Graham number of Cowealth Medical China Co.Ltd. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Cowealth Medical China Co.Ltd. fundamental analysis

No fundamental analysis for Cowealth Medical China Co.Ltd. yet.

Cowealth Medical China Co.Ltd. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Cowealth Medical China Co.Ltd.

Cowealth Medical China Co.,Ltd. operates as a medical company in China. It offers centralized procurement services for in-vitro diagnostic reagents and consumables; platform for decision-making and analysis, commercialization of achievements in medical science and technology; a multi-channel coaxial time audio video imaging platform; and an AI-assisted system for clinical diagnosis. The company was founded in 1997 and is based in Shanghai, China.

Full company profile